Cargando…

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies

BACKGROUND: Glioblastoma multiforme (GBM) is the most common and lethal brain tumor in adults, highlighting the need for novel treatment strategies. Patient derived xenografts (PDX) represent a valuable tool to accomplish this task. METHODS: PDX were established by implanting GBM tissue subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	William, Doreen, Mullins, Christina Susanne, Schneider, Björn, Orthmann, Andrea, Lamp, Nora, Krohn, Mathias, Hoffmann, Annika, Classen, Carl-Friedrich, Linnebacher, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301415/ https://www.ncbi.nlm.nih.gov/pubmed/28183348 http://dx.doi.org/10.1186/s12967-017-1128-5

Ejemplares similares

Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison
por: Mullins, Christina Susanne, et al.
Publicado: (2013)

Amplification of the EGFR gene can be maintained and modulated by variation of EGF concentrations in in vitro models of glioblastoma multiforme
por: William, Doreen, et al.
Publicado: (2017)

Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma
por: William, Doreen, et al.
Publicado: (2018)

The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification
por: Schneider, Björn, et al.
Publicado: (2022)

Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models
por: Gock, Michael, et al.
Publicado: (2016)

Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures
por: Alcaniz, Joshua, et al.
Publicado: (2023)

Optimizing the process of nucleofection for professional antigen presenting cells
por: Mullins, Christina Susanne, et al.
Publicado: (2015)

Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment
por: Prall, Friedrich, et al.
Publicado: (2017)

Cryopreservation of human colorectal carcinomas prior to xenografting
por: Linnebacher, Michael, et al.
Publicado: (2010)

Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
por: Mullins, Christina S., et al.
Publicado: (2019)

Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M
por: Mullins, Christina Susanne, et al.
Publicado: (2019)

Establishment and Characterization of Novel Human Intestinal In Vitro Models for Absorption and First-Pass Metabolism Studies
por: Przybylla, Randy, et al.
Publicado: (2022)

Establishment and characterization of HROC69 – a Crohn´s related colonic carcinoma cell line and its matched patient-derived xenograft
por: Kuehn, Florian, et al.
Publicado: (2016)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Comparing tumor microRNA profiles of patients with long- and short-term-surviving glioblastoma
por: Schneider, Björn, et al.
Publicado: (2022)

Murine Endogenous Retroviruses Are Detectable in Patient-Derived Xenografts but Not in Patient-Individual Cell Lines of Human Colorectal Cancer
por: Bock, Stephanie, et al.
Publicado: (2018)

Microsatellite Status and IκBα Expression Levels Predict Sensitivity to Pharmaceutical Curcumin in Colorectal Cancer Cells
por: Lu, Lili, et al.
Publicado: (2022)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

The HROC-Xenobank—A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models
por: Matschos, Stephanie, et al.
Publicado: (2021)

Glucose Influences the Response of Glioblastoma Cells to Temozolomide and Dexamethasone
por: Bielecka-Wajdman, Anna M, et al.
Publicado: (2022)

Cancer-Cell-Derived IgG and Its Potential Role in Tumor Development
por: Kdimati, Said, et al.
Publicado: (2021)

Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models
por: Riess, Christin, et al.
Publicado: (2021)

AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro
por: Lange, Falko, et al.
Publicado: (2019)

Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells
por: Shang, Yuru, et al.
Publicado: (2021)

Generation, Characterization and Application of Antibodies Directed against HERV-H Gag Protein in Colorectal Samples
por: Mullins, Christina S., et al.
Publicado: (2016)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

HGG-07. CYCLIN-DEPENDENT KINASES AS TARGET STRUCTURES FOR CANCER THERAPY – A COMPARATIVE IN VITRO ANALYSIS ON PATIENT-DERIVED GLIOBLASTOMA CELL CULTURE MODELS
por: Riess, Christin, et al.
Publicado: (2020)

Analyzing non‐cancer causes of death of colorectal carcinoma patients in the US population for the years 2000–2016
por: Lu, Lili, et al.
Publicado: (2020)

Global Association of Cause-specific Mortality between the Major Gastrointestinal Cancers and Parkinson’s Disease for the First Two Decades of the New Millennium
por: Lu, Lili, et al.
Publicado: (2022)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
por: Wagner, Sandra, et al.
Publicado: (2018)

Mouse models of colorectal cancer: Past, present and future perspectives
por: Bürtin, Florian, et al.
Publicado: (2020)

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
por: Riess, Christin, et al.
Publicado: (2020)

Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma
por: Di Sebastiano, Andrea R., et al.
Publicado: (2018)

Radiolabeled novel mAb 4G1 for immunoSPECT imaging of EGFRvIII expression in preclinical glioblastoma xenografts
por: Liu, Xujie, et al.
Publicado: (2016)

IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts
por: Kurbegovic, Sorel, et al.
Publicado: (2021)

A Purdue icon: creation, life, and legacy
por: Mullins, James L
Publicado: (2019)

HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line
por: von den Driesch, Jens, et al.
Publicado: (2023)

Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer in vitro models including the rare pleomorphic subentity
por: Andus, Ingo, et al.
Publicado: (2023)

A Molecularly Characterized Preclinical Platform of Subcutaneous Renal Cell Carcinoma (RCC) Patient-Derived Xenograft Models to Evaluate Novel Treatment Strategies
por: Gürgen, Dennis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ibo5k35pomhf658umemfffj6jn